Drug Product Fill-Finish Services

  • Drug Product Fill-Finish Services 1
  • Drug Product Fill-Finish Services 2
  • Drug Product Fill-Finish Services 3
Product Description

Fill-Finish Capabilities (product type) and Capacity:
Sterile liquid products
Biosafety level (BSL) 1, BSL 2 (OEL >= 10 µg/m³)
Vaccines (inactivated)
Current capacity: ~40M units/year

Read more Show less

INCOG BIOPHARMA SERVICES

  • US
  • 2022
    On CPHI since
  • 1
    Certificates
  • 50 - 99
    Employees
Company types
CMO/CDMO
Primary activities
Analytical Services
Contract Manufacturer
Supply Chain
View company profile
Categories
more categories Show less

INCOG BIOPHARMA SERVICES

  • US
  • 2022
    On CPHI since
  • 1
    Certificates
  • 50 - 99
    Employees
Company types
CMO/CDMO
Primary activities
Analytical Services
Contract Manufacturer
Supply Chain
View company profile

More Products from INCOG BIOPHARMA SERVICES (1)

INCOG BIOPHARMA SERVICES resources (1)

  • Building resiliency into single-use systems

    Sponsored Content Building resiliency into single-use systems

    Jo Anne Jacobs, Director of Technical Services at INCOG BioPharma Services, discusses building a functional equivalence model for single-use manufacturing equipment and assemblies for use in drug product manufacturing. 
    20 May 2022